Research Article
Antioxidant, Anti-Inflammatory, and Cytotoxic Properties and Chemical Compositions of Filipendula palmata (Pall.) Maxim.
Table 5
Antiproliferative activities of compounds against four tumor cell lines (IC50, µg/mL).
| Compound | The IC50 of antiproliferative activity (μg/mL) | MCF-7 | HeLa | 4T1 | A549 |
| Doxorubicin | 65.61 ± 2.25 | 12.52 ± 1.02 | 152.22 ± 7.25 | 10.72 ± 1.11 | 8 | 96.58 ± 3.69 | 46.21 ± 3.33 | 205.15 ± 8.77 | 39.88 ± 2.05 | 9 | 125.66 ± 4.77 | 50.84 ± 4.21 | 181.27 ± 6.99 | 45.55 ± 1.37 | 10 | 68.13 ± 3.54 | 13.22 ± 1.33 | 172.22 ± 8.12 | 29.09 ± 1.22 | 11 | 72.32 ± 2.25 | 16.55 ± 1.25 | 195.66 ± 10.21 | 26.52 ± 1.54 | 12 | 75.65 ± 3.21 | 18.17 ± 1.63 | 230.11 ± 12.11 | 33.55 ± 1.62 | 13 | 80.25 ± 4.12 | 19.22 ± 2.30 | 245.22 ± 10.69 | 52.21 ± 1.39 | 14 | 81.36 ± 2.66 | 22.36 ± 1.89 | 285.66 ± 9.87 | 46.36 ± 1.77 | 15 | 83.64 ± 3.10 | 22.57 ± 2.06 | >400 | 55.30 ± 2.12 | 16 | 110.95 ± 6.21 | 38.24 ± 2.55 | 235.66 ± 13.25 | 39.55 ± 1.25 | 17 | 85.66 ± 4.12 | 21.21 ± 1.78 | 227.55 ± 11.21 | 40.75 ± 2.36 | 18 | 88.63 ± 2.12 | 23.77 ± 2.13 | 265.22 ± 16.32 | 29.36 ± 0.25 | 19 | 86.49 ± 3.82 | 23.84 ± 2.11 | 301.11 ± 18.12 | 35.32 ± 1.89 | 20 | 82.34 ± 2.65 | 20.96 ± 1.21 | >400 | 49.87 ± 1.92 | 21 | 84.47 ± 3.33 | 23.65 ± 1.84 | 322.02 ± 16.14 | 38.65 ± 2.13 | 22 | 85.11 ± 3.58 | 22.31 ± 1.64 | 275.22 ± 11.01 | 42.09 ± 1.69 | 23 | 89.65 ± 2.36 | 24.33 ± 2.12 | 226.22 ± 13.21 | 51.25 ± 2.17 | 24 | 84.29 ± 3.64 | 21.95 ± 1.76 | 352.21 ± 15.62 | 50.12 ± 1.99 |
|
|
vs. control group; vs. model group. The values are means ± standard errors of the experiment carried out in triplicates. |